Skip to content

Clinical Analysis of Oxelidine Combined with Flurbiprofen and Dexmedetomidine for Postoperative Intraumatic Pump in Orthopedic Patients

Clinical Analysis of Oxelidine Combined with Flurbiprofen and Dexmedetomidine for Postoperative Intraumatic Pump in Orthopedic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095858
Enrollment
Unknown
Registered
2025-01-14
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain within 48 hours after orthopedic trauma surgery

Interventions

Oxelidine combined with flurbiprofen and dexmedetomidine:0.4mg/ kg Oxelidine ?4mg/ kg flurbiprofen and dexmedetomidine2 µg/ kg plus normal saline,total 100ml
Sufentanil combined with flurbiprofen and dexmedetomidine:2µg/ kg sufentanil ?4mg/ kg flurbiprofen and dexmedetomidine2 µg/ kg plus normal saline,total 100ml

Sponsors

Shaanxi 215 Hospital of nuclear industry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria: 18-60 years old; 2.BMI: 18.5-30kg/m2; 3.ASA grades I-II; 4.patients requiring postoperative analgesic pump therapy and elective trauma orthopedics surgery;

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria: patients with severe heart, brain, lung, liver, and kidney diseases; 2.long-term use of opioids and sedative drugs, allergic to drug-related ingredients; 3.postoperative transfer to ICU patients;

Design outcomes

Primary

MeasureTime frame
Visual Analog Pain Scale (VAS) at 6, 12, 24, and 48 h postoperatively.;

Secondary

MeasureTime frame
Number of uses of PCA;Changes in inflammatory markers within 24 hours after surgery;Patient satisfaction;Incidence of nausea and vomiting;First anal exhaust time;Urethral extraction time;postoperative hospital stay;

Countries

China

Contacts

Public ContactLiuqin Jiang

Shaanxi 215 Hospital of nuclear industry

jlq215hp@163.com+86 29 32088348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026